China's Best One-Stop Medical Equipment Provider
About

BioView is a medical technology company based in Israel, founded in 2000, with a subsidiary in the United States focused on sales and support. The company specializes in developing and marketing automated cell imaging and analysis solutions for cytology, cytogenetics, pathology, and clinical laboratories worldwide. BioView's core products include advanced imaging and analysis platforms that automate the operation of fully motorized microscopes. Key offerings are the Accord and Accord Plus systems for real-time FISH sample analysis, the Allegro Plus for identifying chromosomal abnormalities, and the DUET Imaging and Analysis Platform, which is FDA-cleared for cancer detection applications. The DeNovo System facilitates the detection of circulating tumor cells, while the NGK platform enhances karyotyping efficiency using deep learning technology. The company serves clinical and research laboratories globally, providing tools that streamline workflows and improve diagnostic accuracy. BioView is also developing a noninvasive early detection test for lung cancer, furthering its commitment to enhancing cancer detection capabilities.

Technologies
OutlookRemoteCircle
Keywords
fish analysiscirculating tumor cells detectiondigital pathologykaryotypingtarget fishalk fishros1 fishcll fishher2neu fishfish web analysisai based image analysiscloud applicationsliquid biopsyrare cellsmedical equipment manufacturingmedical equipment and supplies manufacturingautomated imagingregulatory approvalsnoninvasive lung cancer detectionclinical laboratory solutionsbiomarker analysiscytologymedical devicesfda clearanceimage analysis algorithmsb2blaboratory workflow automationhigh-resolution camerasmultiplex fish assayautomated cell imaging
Company Information
  • Employees36
  • Founded2000
  • Annual Revenue$7990000
Location

44 Manning Rd, Billerica, Massachusetts, United States, 01821

Related Companies
Companies in the same industry